Literature DB >> 9398605

Structural characterization of mouse monoclonal antibody 13-1 against a porphyrin derivative: identification of a disulfide bond in CDR-H3 of Mab 13-1.

S Akashi1, K Kato, T Torizawa, N Dohmae, H Yamaguchi, M Kamachi, A Harada, T Imanaka, I Shimada, K Takio.   

Abstract

The amino acid sequence of a mouse monoclonal antibody Mab13-1, a catalytic antibody against TCPP (meso-tetrakis(4-carboxyphenyl)porphyrin), was confirmed by mass spectrometric (MS) peptide mapping. The amino-terminal sequence of the heavy chain was established by MS/MS analysis of the isolated N-terminal peptide. The presence of a unique disulfide bond between Cys93H and Cys102H was identified by MS peptide mapping and sequence analysis of an S-S containing peptide. Positions of other disulfide bonds were identified to be conserved. The non-conserved disulfide bridge was found to be resistant as other intra-chain disulfide bonds against reduction under non-denaturing condition, and to be buried inside the molecule. This extra disulfide bond is expected to support antigen-binding by restricting the flexibility of CDR-H3 loop, and it might be favorable for the recognition of a plane antigen, a porphyrin derivative.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398605     DOI: 10.1006/bbrc.1997.7668

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Chemical modification of a catalytic antibody that accelerates the hydrolysis of carbonate esters.

Authors:  H Suzuki; Y Higashi; N Naitoh; C Yamamoto; S Nakamura; Y Kawamura-Konishi
Journal:  J Protein Chem       Date:  2000-07

2.  Design and activity of a murine and humanized anti-CEACAM6 single-chain variable fragment in the treatment of pancreatic cancer.

Authors:  Christopher J Riley; Kevin P Engelhardt; Jose W Saldanha; Wenqing Qi; Laurence S Cooke; Yingting Zhu; Satya T Narayan; Kishore Shakalya; Kimiko Della Croce; Ivan G Georgiev; Raymond B Nagle; Harinder Garewal; Daniel D Von Hoff; Daruka Mahadevan
Journal:  Cancer Res       Date:  2009-02-24       Impact factor: 12.701

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.